Weight Reduction Risky While Sheltering in Place
Persons with obesity are at greater risk for poor health during the COVID-19 quarantine. But, obesity expert Donna Ryan, MD, advises against wieght loss during this time.
New NIH COVID-19 Treatment Guidelines, No Approved Drugs
There is no pharmacologic agent proven to be safe and effective for treating COVID-19, according to guidelines compiled by an NIH-assembled panel of experts.
Adipose Tissue in Obesity Linked to Prothrombotic State
Leading researcher Donna Ryan, MD, discusses how adipose tissue contributes to inflammation and prothrombotic risk in persons with obesity.
Chest X-ray Findings Normal in Patients with Confirmed COVID-19
A normal chest X-ray is no guarantee that a patient is not infected with SARS-CoV-2, suggest results of a new study in ambulatory patients.
COVID-19 Impressions & Misconceptions in the US and UK
One-quarter of US and UK adults indicated a package from China may transmit the SARS-CoV-2 virus. Click through more perceptions, true and false, from a recent survey.
NIH Launches Public-Private Collaborative to Boost Global COVID-19 Response
To speed progress toward COVID-19 preventives and treatments, health agencies and leading pharmaceutical companies will contribute expertise, infrastructure, and funding.
Sanofi, GSK Partner to Develop COVID-19 Vaccine
Phase I clinical trials of the adjuvanted vaccine against the SARS-CoV-2 virus could begin in the second half of 2020, according to the companies.
Obesity, Inflammation Increase Risk for Critical Illness in COVID-19 Patients
In the US, where 40% of adults meet criteria for obesity, results of 2 new case series have important clinical implications for patient care during the pandemic.
Obesity and COVID-19: Very Dangerous Together
VIDEO: Patients with obesity are at increased risk for the SARS-CoV-2 infection and for more dangerous complications, explains obesity researcher Donna Ryan, MD.
COVID-19: CMS Rules Suspended to Augment Frontline Staff at Healthcare Facilities
The changes waive a variety of supervision and certification requirements, streamlining hiring and placement.
NIH Clinical Trial of Hydroxychloroquine for COVID-19 Begins
The NIH announced a clinical trial to evaluate hydroxychloroquine safety and efficacy in patients hospitalized with COVID-19.
Return to Work Criteria for HCP After COVID-19
CDC return-to-work criteria for healthcare workers with confirmed or suspected COVID-19 are publisehd to guide administrative decision making.
When No Facemasks are Available: CDC Options
When the face masks are gone, how does care for COVID-19 patients continue? The CDC provides 6 work-arounds to protect HCP.
Experimental COVID-19 Treatments May Put CVD Patients at Risk
Hydroxychloroquine and azithromycin are proposed as treatments for COVID-19 but in patients with existing CV disease could be deadly.
Exposed but Asymptomatic: CDC Guidance on Work Safety
New CDC interim guidance for essential workers exposed to COVID-19 outlines precautions for employee and employer.
Hydroxychloroquine to be Tested as COVID-19 Prophylaxis
Health care workers and first responders will be volunteer participants in the Henry Ford Health System trial of the drug as preventive therapy against COVID-19.
AAFP Chapter Calls for Smoking/Vaping Ban During COVID-19 Pandemic
The New York state chapter of the AAFP cites grim statistics from China on COVID-19 disease progression in smokers vs nonsmokers.
Called from Primary Care to the ICU? 12 Questions You Need to Ask
In response to COVID-19-related staff shortages, ambulatory physicians may be asked to move to emergency or inpatient care. The AAFP offers a guide to make sure you are protected.
HHS Survey Finds US Hospital Pandemic Response Severely Challenged
Inadequate testing supplies and compromised safety of frontline healthcare providers lead hospitals' challenges, according to new OIG report.
States Best & Least Prepared to Manage COVID-19
A state's preparedness to manage the COVID-19 shock to its health system might be assessed by looking at its foundational health care resources.
Strategies for Optimizing Isolation Gown Supply: Contingency & Crisis
Supplies of isolation gowns for healthcare providers caring for patients with COVID-19 are so low that CDC recommends re-use of single-use gowns.
Rapid Response to COVID-19 Survey Helps Inform Predictive Models in Nevada
In Nevada, 14 000 citizens quickly report on COVID-19 signs and symptoms to enhance predictive public health models and inform containtment strategies for the state.
FDA Orders All Ranitidine Products Removed from the Market
The FDA has accumulated sufficient evidence to conclude a contaminant found in ranitidine is a danger to the public.
COVID-19: China's Experience with Signs, Symptoms, & Severity
The statistics on COVID-19 signs, symptoms, progression, and spread in China put the world on notice.
A Diabetes Emergency Plan: 8 Tips to Help Patients Stay Prepared
For your diabetes patients at home or soon to be at home, use these tips from the ADA and AACE on creating an emergency plan.
ACP Applauds CMS Payment for Audio Phone Visits During Pandemic
Telehealth patient visits that use telephone audio only now will be reimbursed by CMS, a move lauded by the American College of Physicians.
3 Strategies to Optimize Facemask Supply: Conventional, Contingency & Crisis Plans
The CDC outlines 3 surge capacity strategies to help healthcare providers prioritize COVID-19-related conservation of facemasks: conventional, contingency, and crisis.
REDUCE-IT Substudy: Higher EPA, Not Lower TGs Associated with Reduced CV Events
ACC.20/WCC. Increased blood levels of eicosapentaenoic acid and not reduced triglycerices may explain reduction in cardiovascular events and death seen in REDUCT-IT study.
Quarantined Patients: 5 Tips on How to Stay Connected
For your patients confined to home, whether ill or out of caution, regular virtual contact to check on status and serve as a trusted resource is important. Here are 5 tips on how to do it.
Genitically-guided Antiplatelet Therapy May Have Early Benefit After PCI
ACC.2020/WCC. The TAILOR-PCI trial found benefit to genotype-guided therapy in first 3 months post-PCI, although 1-year results fell short.
